Skip to main content
. Author manuscript; available in PMC: 2021 Jul 27.
Published in final edited form as: J Child Psychol Psychiatry. 2020 Feb 4;61(3):312–332. doi: 10.1111/jcpp.13202
Term Term Definition
Treatment-resistant depression Clinically impairing depression symptoms despite an adequate trial of an evidence-based psychotherapy and an antidepressant with Grade A evidence for treating depression in pediatric population (fluoxetine, escitalopram, or sertraline)
Treatment-refractory depression Clinically impairing depression symptoms despite an adequate trial of an evidence-based psychotherapy and at least 2 antidepressants with Grade A evidence for treating depression including at least 1 with Grade A evidence in pediatric populations (fluoxetine, escitalopram, or sertraline)
Remission Minimal symptoms of depression after treatment
Response Substantial improvement in depression symptoms with treatment. Greater than a 50% improvement in depression symptoms
Partial response Modest improvement in depression symptoms with treatment. Defined as a 25%–49% improvement in depression symptoms
Nonresponse Minimal-to-no improvement in depression symptoms with treatment. Defined as a less than 25% improvement in depression symptoms